Article Information
PMID
Published By
Print ISSN
1109-6535
Online ISSN
1790-6245
History
- Received May 9, 2024
- Revision received July 12, 2024
- Accepted July 19, 2024
- Published online August 27, 2024.
Copyright & License
Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- MASAYA MORI1,
- HIROMI II1,
- MITSUGU FUJITA2,
- KOZUE NOSE1,
- AYAKO SHIMADA1,
- RISA SHIRAKI1,
- YUHI SONE1,
- CHIAMI MOYAMA1,*,
- KEIKO TANIGUCHI3 and
- SUSUMU NAKATA1⇑
- 1Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan;
- 2Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka-Sayama, Japan;
- 3Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
- Correspondence to: Susumu Nakata, MD, Ph.D., Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, Misasagi-Nakauchicho 5, Yamashina-ku, Kyoto 607-8414, Japan. Tel: +81 755954719, e-mail: snakata{at}mb.kyoto-phu.ac.jp






